Biochemical Markers in Covid-19 Patients in Tripoli, Libya; A Retrospective Study
DOI:
https://doi.org/10.54361/Ljmr18-1.21Keywords:
Covid, Biochemica, parameters, Retrospective, Tripoli,, LibyaAbstract
Covid 19 can cause fatal pneumonia and serious complications. In the course of the disease the levels of different biochemical parameters increased and these parameters provide important information about the prognosis of the disease. The aim of this study was to investigate these biomarkers and to evaluate the relationship between biochemical parameters and length of stay in Covid 19 patients. A retrospective study was conducted from October 2020 to December 2021. A total of 156 Covid 19 patients hospitalized in Meitiga Military hospital were included. The demographic characteristics, length of stay, and
biochemical parameters of the patients were scanned from the hospital's database and patient files and recorded. Patients were grouped according to the length of stay; 1st group: after 3 to 5 days, 2nd group: from 8 to 12 days, and 3rd group: after 13 days and more. Most of admitted cases were males, the majority of the participants were in age above 65 years old. CRP, FER, LDH, and D-dimer were gradually increased to the maximum mean; 131.4±67, 1052.3±710.1, 586±128.9, and 1196.2±409.1, respectively after 8 to 12 days and return to normal range after 13 days. To conclude, there is a positive correlation between the levels of these biomarkers and the prolongation of hospitalization in COVID-19 patients and these parameters can be associated with the severity disease.
Downloads
References
Higgins, J. P., et al., (2003). Measuring inconsistency in meta-analyses. Bmj, 327(7414), 557-560.
Lippi, G., & Henry, B. M. (2020). Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19). Respiratory medicine, 167, 105941.
Guan, W. J., et al., (2020). Clinical characteristics of coronavirus disease 2019 in China. New England journal of medicine, 382(18), 1708-1720.
Xiang, J., et al., (2020). Potential biochemical markers to identify severe cases among COVID-19 patients. MedRxiv, 2020-03.
Shereen, M. A., et al., (2020). COVID-19 infection: Emergence, transmission, and characteristics of human coronaviruses. Journal of advanced research, 24, 91-98.
Asghar, M. S., et al., (2021). Correlation of refractory hypoxemia with biochemical markers and clinical outcomes of COVID-19 patients in a developing country: A retrospective observational study: Running head: Predictors of hypoxemia in COVID-19. Journal of Community Hospital Internal Medicine Perspectives, 11(1), 9-16.
World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. Available from: https://COVID19.who.int/ . Accessed 2023 (Sep 01).
Wang, D., et al., (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. jama, 323(11), 1061-1069.
Huang, C., et al., (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 395(10223), 497-506.
Palaiodimos, L., et al., (2020). Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism, 108, 154262.
Cowling, B. J., & Aiello, A. E. (2020). Public health measures to slow community spread of coronavirus disease 2019. The Journal of infectious diseases, 221(11), 1749-1751.
Liu, X., Zhang, R., & He, G. (2020). Hematological findings in coronavirus disease 2019: indications of progression of disease. Annals of hematology, 99, 1421-1428.
Sato, H., Tsubosa, Y., & Kawano, T. (2012). Correlation between the pretherapeutic neutrophil to lymphocyte ratio and the pathologic response to neoadjuvant chemotherapy in patients with advanced esophageal cancer. World journal of surgery, 36, 617-622.
Martins, E. C., et al., (2019). Neutrophil-lymphocyte ratio in the early diagnosis of sepsis in an intensive care unit: a case-control study. Revista Brasileira de terapia intensiva, 31, 64-70.
Ciaccio, M., & Agnello, L. (2020). Biochemical biomarkers alterations in Coronavirus Disease 2019 (COVID-19). Diagnosis, 7(4), 365-372.
Peiró, Ó. M., et al., (2021). Biomarkers and short-term prognosis in COVID-19. Biomarkers, 26(2), 119-126.
Anani, M., et al., (2022). Evaluation of blood and biochemical parameters of COVID-19 patients in Suez Canal University Hospital; A retrospective study. The Journal of Infection in Developing Countries, 16(04), 592-599.
Capraru, I. D., et al., (2023). COVID-19 Biomarkers Comparison: Children, Adults and Elders. Medicina, 59(5), 877.
Yuan, X., et al., (2020). Changes of hematological and immunological parameters in COVID-19 patients. International journal of hematology, 112, 553-559.
Delen, L. A., ERDOĞAN, E., & YAŞAR, Ş. (2021). The Risk Factors Affecting Length of Stay and Mortality in Covid 19 Patients: Laboratory Parameters, Comorbidities, and Demographic Characteristics. Konuralp Medical Journal, 13(S1), 474-478.
Wong, R. S., et al., (2003). Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. Bmj, 326(7403), 1358-1362.
HUSSEIN, S. Z. (2022). The relationship of some biochemical markers with inflammatory prognosis in COVID-19 patients. Modern Medicine, 29(3).
Chen, W., et al., (2020). Plasma CRP level is positively associated with the severity of COVID-19. Annals of clinical microbiology and antimicrobials, 19(1), 1-7.
Yuan, J., et al., (2020). The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients. Inflammation Research, 69, 599-606.
Ji, D., et al., (2020). Clinical characteristics predicting progression of COVID-19.
Liu, J., et al., (2020). Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine, 55.
Deng, X., et al., (2020). Blood biochemical characteristics of patients with coronavirus disease 2019 (COVID-19): a systemic review and meta-analysis. Clinical Chemistry and Laboratory Medicine (CCLM), 58(8), 1172-1181.
Danese, E., & Montagnana, M. (2016). An historical approach to the diagnostic biomarkers of acute coronary syndrome. Annals of translational medicine, 4(10).
Martha, J. W., Wibowo, A., & Pranata, R. (2022). Prognostic value of elevated lactate dehydrogenase in patients with COVID-19: a systematic review and meta-analysis. Postgraduate medical journal, 98(1160), 422-427.
Szarpak, L., et al., (2021). Lactate dehydrogenase level as a COVID-19 severity marker. Am J Emerg Med, 45(45), 638-9.
Tang, N., et al., (2020). Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. Journal of thrombosis and haemostasis, 18(5), 1094-1099.
Aboughdir, et al., (2020). Prognostic value of cardiovascular biomarkers in COVID-19: a review. Viruses, 12(5), 527.
Zhang, L., et al., (2020). D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐19. Journal of thrombosis and haemostasis, 18(6), 1324-1329.
Ye, W., et al., (2020). Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19. Respiratory research, 21(1), 1-7.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 V, Zeineb Alsharef , Takwa Miftah, Gofran Enwere (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Open Access Policy
Libyan journal of medical Research (LJMR).is an open journal, therefore there are no fees required for downloading any publication from the journal website by authors, readers, and institution.
The journal applies the license of CC BY (a Creative Commons Attribution 4.0 International license). This license allows authors to keep ownership f the copyright of their papers. But this license permits any user to download , print out, extract, reuse, archive, and distribute the article, so long as appropriate credit is given to the authors and the source of the work.
The license ensures that the article will be available as widely as possible and that the article can be included in any scientific archive.
Editorial Policy
The publication of an article in a peer reviewed journal is an essential model for Libyan journal of medical Research (LJMR). It is necessary to agree upon standards of expected ethical behavior for all parties involved in the act of publishing: the author, the journal editorial, the peer reviewer and the publisher.
Any manuscript or substantial parts of it, submitted to the journal must not be under consideration by any other journal. In general, the manuscript should not have already been published in any journal or other citable form, although it may have been deposited on a preprint server. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights, or the rights of a third party.
Authorship Policy
The manuscript authorship should be limited to those who have made a significant contribution and intellectual input to the research submitted to the journal, including design, performance, interpretation of the reported study, and writing the manuscript. All those who have made significant contributions should be listed as co-authors.
Others who have participated in certain substantive aspects of the manuscript but without intellectual input should only be recognized in the acknowledgements section of the manuscript. Also, one of the authors should be selected as the corresponding author to communicate with the journal and approve the final version of the manuscript for publication in the LJMR.
Peer-review Policy
- All the manuscripts submitted to LJMR will be subjected to the double-blinded peer-review process;
- The manuscript will be reviewed by two suitable experts in the respective subject area.
- Reports of all the reviewers will be considered while deciding on acceptance/revision or rejection of a manuscript.
- Editor-In-Chief will make the final decision, based on the reviewer’s comments.
- Editor-In-Chief can ask one or more advisory board members for their suggestions upon a manuscript, before making the final decision.
- Associate editor and review editors provide administrative support to maintain the integrity of the peer-review process.
- In case, authors challenge the editor’s negative decision with suitable arguments, the manuscript can be sent to one more reviewer and the final decision will be made based upon his recommendations.
